1. Solomons N. Trace Elements. In‘Clinical Nutrition: Parenteral Nutrition’ 2nd edition.
Philadelphia, USA.1993; pp. 150-183.
2. Standbury J.B. and Kroc R.L.Human Development and the Thyroid Gland:Relation to
Endemic Cretinism, PlenumPress, New York.2000; p 19.
3. Tapiero H. and Tew K.D. Trace elements in human physiology and pathology: zinc
and metallothioneins.Biomedicine and Pharmocotherapy 2003;57 (9): 399-411.
4. Stefanidou M., Maravelias C., Dona A., and Spiliopoulou C. Zinc: a
multipurpose trace element. Arch Toxicology,2006; 80 (1): 1-9.
5. Aschner M. Manganese as a potential confounder of serum prolactin. Environ Health
Perspective 2006;114(8):A458.
6. Schomburg L. and Köhrle J.On the importance of selenium and iodine metabolism for thyroid
hormone biosynthesis and human health. Mol Nutrition Food Research 2008;52 (11):
1235- 46.
Indian Journal of Basic & Applied Medical Research; September 2012: Vol.-1, Issue-4, P. 251-258
257
www.ijbamr.com
7. Kvicala J. and Zamrazil V. Effect of iodine and selenium upon thyroid function. Cent-
Eur-J-Public-Health. 2003;11(2): 107-13.
8. Burk RF: Selenium, an antioxidant nutrient. Nutr. Clin. Care.2002; 5:75– 79.
9. Cao YZ, Reddy CC, Sordillo LM: Altered eicosanoid biosynthesis in selenium-deficient
endothelial cells. Free Radic Biol Med.2000; 28: 381–389.
10. Steinberg D: Antioxidants and atherosclerosis. A current assessment. Circulation.1991;
84:1420-1425.
11 . Douillet C, Bost M, Accominotti M, Borson-Chazot F, Ciavatti M: Effect of selenium and
vitamin E supplementation on lipid abnormalities i plasma, aorta, and adipose tissue of
Zucker rats. Trace Elem Res.1998; 65:221–236.
12. Stapleton SR: Selenium: an insulin-mimetic. Cell Mol Life Sci 2000; 57:1874–1879.
13. Levander OA: A global view of human selenium nutrition. Annu Rev Nutr.1987;7:227–250.
14. Robbins J. Factors altering thyroid hormone metabolism. Environ Health Perspect 1981;38:
65-70.
15. Kohrle J, Spanka M, Irmscher K, Hesch RD. Flavonoid effects on transport, metabolism and
action of Visser TJ. Pathways of thyroid hormon metabolism. Acta. Med.
Austriaca,1996;23:10-16.
16. Kohrle J. Thyroid hormone deiodinases--a selenoenzyme family acting as gate keepers to
thyroid Hormone action. Acta Med Austriaca 1996;23:17- 30.
17. Chopra IJ. An assessment of daily production and significance of thyroidal secretion of
3,3',5' triiodithyronine (reverse T3) in man. J Clin Invest.1976:58:32-40.
18. Utiger R. Decreased extrathyroidal triiodothyronine production in non-thyroidal illness:
benefit or harm? Am J Med 1980;69:807-810.
19. St Germain DL, Galton VA. The deiodinase family of selenoproteins. Thyroid 1997;7:655-
668.
20. Beckett GJ, Arthur JR. Hormone-nuclear receptor interactions in health and disease. The
Iodothyronine deiodinases and 5'-deiodination. Baillieres Clin Endocrinol Metab 1994;8:285-
304.
21. Perros P, Mc Crimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic
patients: Value of annual screening. Diabet Med 1995; 12 (7): 622-627.
22. Schlienger JL, Anceau A, Chabrier G, North ML, Stephan F. Effect of diabetic control on the
level of circulating thyroid hormones. Diabetologia.1982; 22; 486-8.
23. Donckier JE. Endocrine diseases and diabetes. In: Text book of Diabetes mellitus. Pickup
JC,Williams G (eds), Blackwell Publishing Company, Chichester, 2003: 27.1 – 27.25.
24. Coiro V, Volpi R, Marchesi C, et al. Influence of residual C-peptide secretion on nocturnal
serum TSH peak in well-controlled diabetic patients. Clin.Endocrinol. 1997; 47: 305-10.
25. O’Mara BA, Dittrich W, Lauterio TJ & St Germain DL; Pretranslational regulation of
Indian Journal of Basic & Applied Medical Research; September 2012: Vol.-1, Issue-4, P. 251-258
258
www.ijbamr.com
type I 5 – deiodinase by thyroid hormones and in fasted and diabetic rats. Endocrinology
1993;133: 1715–1723.
26. Polikar R, Burger AG, Scherrer U, et al. The thyroid and the heart. Circulation.1993;
87:1435–1441.
27.Wiersinga WM, Lie KI, Toubler JL. Thyroid hormones in acute myocardial infarction. Clin
Endocrinol. 1981; 14: 367–374.
28. Dillmann WH: Biochemical basis of thyroid hormone action in the heart. Am J
Med.1990;88:626-630.
29. Kabadi UM, Premachandra BN, Maayan M. Low serum 3, 5, 3'-triiodothyronine (T3) and
raised 3, 3', 5'-triidothyronine (reverse T3 or RT3) in diabetes mellitus: normalization on
improvement in hyperglycemia. Acta Diabetol Lat. 1982 Jul-Sep;19(3):233-42.
30. Tahirović H, Dućić V, Smajić A. Euthyroid sick syndrome in type I diabetes mellitus in children and adolescents.
Acta Paediatr Hung. 1991;31(1):67-73.
Thank you for copying data from http://www.arastirmax.com
